Han Sun Kim

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Prognostic Factors

Dendritic Cells

Ejection Fraction

Top Venues

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Han Sun Kim, Doyeon Kim, Jiwoo Kim, Sunghyouk Park, Arvie Camille V de Guzman
SCD and MTHFD2 inhibitors for high-risk acute myeloid leukaemia patients, as suggested by ELN2017-pathway association. Clinical and translational medicine 13 (7) (2023)
Han Sun Kim, Doyeon Kim, Jiwoo Kim, Sunghyouk Park, Arvie Camille V de Guzman
SCD and MTHFD2 inhibitors for high-risk acute myeloid leukaemia patients, as suggested by ELN2017-pathway association. Clinical and translational medicine 13 (7) (2023)
Han Sun Kim, Doyeon Kim, Jiwoo Kim, Sunghyouk Park, Arvie Camille V de Guzman
SCD and MTHFD2 inhibitors for high-risk acute myeloid leukaemia patients, as suggested by ELN2017-pathway association. Clinical and translational medicine 13 (7) (2023)